Zenith Drugs Limited (NSE:ZENITHDRUG)

Zenith Drugs Statistics

Total Valuation

Zenith Drugs has a market cap or net worth of INR 805.99 million. The enterprise value is 1.32 billion.

Market Cap	805.99M
Enterprise Value	1.32B

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Zenith Drugs has 17.15 million shares outstanding. The number of shares has decreased by -70.12% in one year.

Current Share Class	17.15M
Shares Outstanding	17.15M
Shares Change (YoY)	-70.12%
Shares Change (QoQ)	-90.09%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 21.37.

PE Ratio	21.37
Forward PE	n/a
PS Ratio	0.56
PB Ratio	1.12
P/TBV Ratio	1.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	34.94
EV / Sales	0.92
EV / EBITDA	9.70
EV / EBIT	15.92
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.72.

Current Ratio	1.43
Quick Ratio	0.75
Debt / Equity	0.72
Debt / EBITDA	3.81
Debt / FCF	n/a
Interest Coverage	2.38

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	4.33%
Return on Capital Employed (ROCE)	9.78%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	7.90M
Profits Per Employee	207,549
Employee Count	182
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Zenith Drugs has paid 21.00 million in taxes.

Income Tax	21.00M
Effective Tax Rate	35.73%

Stock Price Statistics

The stock price has decreased by -47.05% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-47.05%
50-Day Moving Average	52.27
200-Day Moving Average	66.88
Relative Strength Index (RSI)	36.40
Average Volume (20 Days)	10,880

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Zenith Drugs had revenue of INR 1.44 billion and earned 37.77 million in profits. Earnings per share was 2.20.

Revenue	1.44B
Gross Profit	484.59M
Operating Income	82.91M
Pretax Income	58.78M
Net Income	37.77M
EBITDA	136.08M
EBIT	82.91M
Earnings Per Share (EPS)	2.20

Balance Sheet

The company has 4.96 million in cash and 518.86 million in debt, with a net cash position of -513.90 million or -29.97 per share.

Cash & Cash Equivalents	4.96M
Total Debt	518.86M
Net Cash	-513.90M
Net Cash Per Share	-29.97
Equity (Book Value)	717.15M
Book Value Per Share	41.76
Working Capital	349.79M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 33.69%, with operating and profit margins of 5.76% and 2.63%.

Gross Margin	33.69%
Operating Margin	5.76%
Pretax Margin	4.09%
Profit Margin	2.63%
EBITDA Margin	9.46%
EBIT Margin	5.76%
FCF Margin	n/a

Dividends & Yields

Zenith Drugs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	70.12%
Shareholder Yield	70.12%
Earnings Yield	4.69%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1